Restorative cell therapy for Parkinson's disease: A quest for the perfect cell
(2007) In Seminars in Cell & Developmental Biology 18(6). p.859-869- Abstract
- The development of a cell therapy for the neurodegenerative disorder Parkinson's disease is a realistic ambition. It is pursued by researchers and companies alike, and spans different donor tissue types of embryonic, fetal and adult origins. In this review, we briefly outline the past and current status of research and clinical trials with cell transplantation in Parkinson's disease. We discuss studies on donor tissue derived from embryonic ventral mesencephalon and assess the current research on various forms of stem cells of both embryonic and adult origins in the quest to develop a cell-based therapy for this debilitating movement disorder.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1139812
- author
- Hall, Vanessa LU ; Li, Jia-Yi LU and Brundin, Patrik LU
- organization
- publishing date
- 2007
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Seminars in Cell & Developmental Biology
- volume
- 18
- issue
- 6
- pages
- 859 - 869
- publisher
- Academic Press
- external identifiers
-
- pmid:17962052
- wos:000253486700016
- scopus:36249002320
- ISSN
- 1084-9521
- DOI
- 10.1016/j.semcdb.2007.09.004
- language
- English
- LU publication?
- yes
- additional info
- The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Neuronal Survival (013212041), Neural Plasticity and Repair (013210080)
- id
- 4fd73671-d1eb-45b6-a103-f356f7ec57d2 (old id 1139812)
- date added to LUP
- 2016-04-01 15:32:02
- date last changed
- 2022-01-28 05:49:04
@article{4fd73671-d1eb-45b6-a103-f356f7ec57d2, abstract = {{The development of a cell therapy for the neurodegenerative disorder Parkinson's disease is a realistic ambition. It is pursued by researchers and companies alike, and spans different donor tissue types of embryonic, fetal and adult origins. In this review, we briefly outline the past and current status of research and clinical trials with cell transplantation in Parkinson's disease. We discuss studies on donor tissue derived from embryonic ventral mesencephalon and assess the current research on various forms of stem cells of both embryonic and adult origins in the quest to develop a cell-based therapy for this debilitating movement disorder.}}, author = {{Hall, Vanessa and Li, Jia-Yi and Brundin, Patrik}}, issn = {{1084-9521}}, language = {{eng}}, number = {{6}}, pages = {{859--869}}, publisher = {{Academic Press}}, series = {{Seminars in Cell & Developmental Biology}}, title = {{Restorative cell therapy for Parkinson's disease: A quest for the perfect cell}}, url = {{http://dx.doi.org/10.1016/j.semcdb.2007.09.004}}, doi = {{10.1016/j.semcdb.2007.09.004}}, volume = {{18}}, year = {{2007}}, }